Estramustine phosphate sodium
Code | Size | Price |
---|
TAR-T4451-10mg | 10mg | £118.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T4451-50mg | 50mg | £149.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T4451-100mg | 100mg | £182.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Estramustine phosphate sodium is an antimicrotubule chemotherapy agent; arrests prostate cancer cells in the G2/M phase of the cell cycle.
CAS:
52205-73-9
Formula:
C23H30Cl2NNa2O6P
Molecular Weight:
564.35
Pathway:
Apoptosis; Cytoskeletal Signaling
Purity:
0.9954
SMILES:
[Na+].[Na+].CC12CCC3C(CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)C1CCC2OP([O-])([O-])=O
Target:
Apoptosis; Microtubule Associated
References
Perry CM,etal.Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.Drugs Aging. 1995 Jul;7(1):49-74.
Bergenheim AT,etal.Pharmacokinetics and pharmacodynamics of estramustine phosphate.Clin Pharmacokinet. 1998 Feb;34(2):163-72.
Dene Simpson, et al. Estramustine Phosphate Sodium. American Journal of Cancer 2 (5): 373?390.